<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HPQ</journal-id>
<journal-id journal-id-type="hwp">sphpq</journal-id>
<journal-id journal-id-type="nlm-ta">J Health Psychol</journal-id>
<journal-title>Journal of Health Psychology</journal-title>
<issn pub-type="ppub">1359-1053</issn>
<issn pub-type="epub">1461-7277</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1359105311419268</article-id>
<article-id pub-id-type="publisher-id">10.1177_1359105311419268</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diagnostic profiles determined by the C.A.R.T procedure: IBD patients and fatigue</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Banovic</surname><given-names>Ingrid</given-names></name>
<xref ref-type="aff" rid="aff1-1359105311419268">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gilibert</surname><given-names>Daniel</given-names></name>
<xref ref-type="aff" rid="aff2-1359105311419268">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jebrane</surname><given-names>Ahmed</given-names></name>
<xref ref-type="aff" rid="aff3-1359105311419268">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cosnes</surname><given-names>Jacques</given-names></name>
<xref ref-type="aff" rid="aff4-1359105311419268">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1359105311419268"><label>1</label>Laboratoire IPSé (EA 4432)-Paris Ouest-Nanterre- La Défense, France</aff>
<aff id="aff2-1359105311419268"><label>2</label>Université de Bourgogne, France</aff>
<aff id="aff3-1359105311419268"><label>3</label>Institut Mathématiques de Bourgogne, France</aff>
<aff id="aff4-1359105311419268"><label>4</label>Université Pierre et Marie Curie, Paris VI, France</aff>
<author-notes>
<corresp id="corresp1-1359105311419268">Ingrid Banovic, Université de Bourgogne-Laboratoire Ipsé-Paris 10-Nanterre, Pôle AAFE, Esplanade Erasme, B.P. 26 513, 21065 Dijon Cedex. Email: <email>Ingrid.Banovic@u-bourgogne.fr</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>17</volume>
<issue>4</issue>
<fpage>500</fpage>
<lpage>508</lpage>
<permissions>
<copyright-statement>© The Author(s) 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Fatigue is common in IBD. It remains a complex phenomenon with primary factors related to the disease and secondary factors (depression, anxiety, sleep disturbances, pain) whose respective importance and organization are difficult to determine. By using the C.A.R.T. procedure, the diagnostic variables of 108 IBD-related fatigue patients were determined globally, according to their sex and the clinical activity of their disease. Results underline the diversity of diagnostic profiles in which psychological variables have significant influence. It is important to consider fatigue according to profiles that best illustrate its complexity and allow for identifying better potentially remediable factors.</p>
</abstract>
<kwd-group>
<kwd>anxiety</kwd>
<kwd>C.A.R.T procedure</kwd>
<kwd>depression</kwd>
<kwd>fatigue</kwd>
<kwd>IBD</kwd>
<kwd>sleep disorders</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Fatigue is considered as a complex phenomenon in chronic disease (<xref ref-type="bibr" rid="bibr2-1359105311419268">Bardwell &amp; Ancoli-Israel, 2008</xref>) with primary factors (concerning the disease) and secondary factors (e.g., depression, anxiety, sleep disturbances; <xref ref-type="bibr" rid="bibr36-1359105311419268">Manzullo &amp; Escalante, 2002</xref>; <xref ref-type="bibr" rid="bibr8-1359105311419268">Borneman et al., 2007</xref>). Physicians often considered fatigue in Inflammatory Bowel Disease (IBD, including Crohn’s Disease and Ulcerative Colitis) as a clinical feature of the disease. The relation between primary factors and fatigue is not systematically linear and causal: IBD patients with an active disease are tired but fatigue persists when the disease is inactive (<xref ref-type="bibr" rid="bibr39-1359105311419268">Minderhoud, Oldenburg, van Dam, van Berge Henegouwen, 2003</xref>).</p>
<p>Moreover, IBD patients suffer from anxiety and depression (<xref ref-type="bibr" rid="bibr38-1359105311419268">Mikocka-Walus, Turnbull, Andrews, Moulding, Holtmann, 2008</xref>; <xref ref-type="bibr" rid="bibr32-1359105311419268">Kovács &amp; Kovacs, 2007</xref>). If psychological suffering is characterized by sleep disturbances (<xref ref-type="bibr" rid="bibr14-1359105311419268">Fava, 2004</xref>; <xref ref-type="bibr" rid="bibr29-1359105311419268">Kaplan &amp; Harvey, 2009</xref>), they are also related to the activity of the disease (<xref ref-type="bibr" rid="bibr24-1359105311419268">Häuser, Janke, Klump, Hinz, 2011</xref>; <xref ref-type="bibr" rid="bibr43-1359105311419268">Ranjbaran, Keefer, Stepanski, Farhadi, Keshvarian, 2007</xref>). Nevertheless, it appears difficult to determine if psychological suffering is the result of the medical condition or if it is due to personal vulnerability (moreover, gender is implicated in variations in intensity and causes; <xref ref-type="bibr" rid="bibr15-1359105311419268">Flett, Baricza, Gupta, Hewitt, Endler, 2011</xref>; <xref ref-type="bibr" rid="bibr17-1359105311419268">Fuhrer &amp; Wessely, 1995</xref>; <xref ref-type="bibr" rid="bibr5-1359105311419268">Bensing, Hulsman, Schreurs, 1999</xref>; <xref ref-type="bibr" rid="bibr22-1359105311419268">Hall, Rubin, Dougall, Hungin, Neely, 2005</xref>). Research in other contexts has sometimes shown that psychological factors seem to determine fatigue (<xref ref-type="bibr" rid="bibr6-1359105311419268">Bodini et al., 2008</xref>; <xref ref-type="bibr" rid="bibr23-1359105311419268">Harvey, Wadsworth, Wessley, Hotopf, 2008</xref>), in other cases they are not so determinant (<xref ref-type="bibr" rid="bibr50-1359105311419268">Watanabe, Stewart, Jenkins, Bhugra, Furukawa, 2008</xref>; <xref ref-type="bibr" rid="bibr37-1359105311419268">Matsuda et al., 2009</xref>). Medical and psychological explanations remain ambiguous (<xref ref-type="bibr" rid="bibr20-1359105311419268">Goldstein et al., 2006</xref>; <xref ref-type="bibr" rid="bibr42-1359105311419268">Raison, Lin, Reeves, 2009</xref>).</p>
<p>If all these factors are involved in fatigue, it seems difficult for the physician to know which information is diagnostic of the fatigue and which variables should be given priority when elaborating a therapeutic response to this complaint. It appears important to determine how and at what level primary and secondary factors are involved in a diagnostic state of fatigue.</p>
<p>The Classification and Regression Trees (CART) method could provide some answers to these questions. This nonparametric statistical procedure (<xref ref-type="bibr" rid="bibr9-1359105311419268">Breiman, Friedman, Olshen, Stone, 1987</xref>; <xref ref-type="bibr" rid="bibr34-1359105311419268">Lemon, Roy Clark, Friedmann, Rakowski, 2003</xref>) could identify the most diagnostic variables of fatigue in a context in which the disease is considered to be the primary cause (<xref ref-type="bibr" rid="bibr49-1359105311419268">Van Langenberg &amp; Gibson, 2010</xref>) even though it persists during periods of remission (<xref ref-type="bibr" rid="bibr27-1359105311419268">Jelsness-Jørgensen, Bernklev, Henriksen, Torp, Moum, 2011</xref>). Fatigue can be diagnosed and treated by the physician depending on the clinical activity of the disease and its medical consequences, and by the psychologist as being related to psychological factors (depression, anxiety, sleep disturbances). In both practices, clinicians base their diagnosis and treatment decisions on determined thresholds. Different diagnostic variables of fatigue could be identified with the CART method, and the most critical and relevant thresholds can be made to take the phenomenon into account. For these reasons, this method is preferable to a multiple regression analysis (its performances would be close to statistical techniques more typically used in multivariate models; <xref ref-type="bibr" rid="bibr11-1359105311419268">Colombet et al., 2000</xref>). It has been used in medicine because it is close to clinical and medical reasoning in terms of diagnostic criteria leading to a therapeutic decision or to identify specific patient profiles (<xref ref-type="bibr" rid="bibr18-1359105311419268">Garzotto et al., 2005</xref>; <xref ref-type="bibr" rid="bibr26-1359105311419268">Hess, Abbruzzese, Lenzi, Raber, Abbruzzese, 1999</xref>). The visual result due to the construction of trees also makes it possible to understand which patient group may potentially be considered as being good or bad respondents to a treatment (<xref ref-type="bibr" rid="bibr12-1359105311419268">De Iudicibus et al., 2011</xref>; Doering et al., 1998; <xref ref-type="bibr" rid="bibr18-1359105311419268">Garzotto et al., 2005</xref>; <xref ref-type="bibr" rid="bibr26-1359105311419268">Hess et al, 1999</xref>; <xref ref-type="bibr" rid="bibr35-1359105311419268">Mañosa et al., 2011</xref>; <xref ref-type="bibr" rid="bibr48-1359105311419268">Teixeira, 2004</xref>).</p>
<p>The aim of this research was to identify diagnostic variables of IBD-related fatigue using the CART method. IBD patients are relevant for research because fatigue is primarily related to the disease although other variables may be involved when it is in remission.</p>
<sec id="section1-1359105311419268" sec-type="methods">
<title>Method</title>
<sec id="section2-1359105311419268">
<title>Sample</title>
<p>The sample was constituted of 118 IBD patients (64 women and 54 men with a medium age of 35.92 (±12, 18) years, 92 with Crohn’s Disease and 26 with Ulcerative Colitis). They were recruited at a Parisian hospital when they had a consultation with their physician or when they had an infusion at the day treatment center. These patients were enrolled after an explanation of the study and they signed an informed consent form.</p>
</sec>
</sec>
<sec id="section3-1359105311419268">
<title>Measures</title>
<p>All the tools used here are readily available to physicians and psychologists taking care of IBD patients.</p>
<p>Fatigue was assessed with the Multidimensional Fatigue Inventory developed by <xref ref-type="bibr" rid="bibr45-1359105311419268">Smets et al. (1995)</xref>. Its French version (<xref ref-type="bibr" rid="bibr19-1359105311419268">Gentile, Delarozière, Favre, Sambuc, San Marco, 2003</xref>) has four dimensions: General Fatigue [GF] (i.e., the general sensation of being tired), Mental Fatigue [MF] (i.e., the cognitive aspects of fatigue), Motivation [Mo] (i.e., the difficulty to imagine enjoying a pleasant activity) and Reduced Activities [RA] (i.e., the patient’s capacity to do physical activities). The score ranges from 9 to 45 for General Fatigue, 6 to 30 for Mental Fatigue, 3 to 15 for Reduced Activities, 2 to10 for Motivation, and 20 to 100 for the MFI global score. MFI allows one to give an overall estimate of fatigue (with a global score) and also to determine a profile of fatigue.</p>
<sec id="section4-1359105311419268">
<title>Assessments of disease activity and perceived gravity</title>
<sec id="section5-1359105311419268">
<title>The Crohn’s Disease Activity Index (CDAI)</title>
<p>Quantifies the symptoms of patients with Crohn’s Disease for seven days, and includes eight factors (number of liquid stools each day, abdominal pain, general well-being, presence of complications, taking medicine for diarrhea, presence of abdominal mass, absolute deviation of Hematocrit and percentage deviation for standard weight) totaled after adjustment with a weighting factor. A CDAI under 150 indicates remission.</p>
</sec>
<sec id="section6-1359105311419268">
<title>The Lichtiger score or modified Truelove and Witts Index</title>
<p>Assesses the severity of ulcerative colitis (<xref ref-type="bibr" rid="bibr33-1359105311419268">Lichtiger et al., 1994</xref>). It quantifies: a) number of stools each day, b) the presence of nocturnal diarrhea, c) frequency of rectorragies, d) anal incontinence, e) pain or abdominal cramps, f) subjective well-being, g) abdominal palpation, h) the necessity to take medicine for diarrhea. The maximal score is 21. A score superior to 10 indicates a severe flare-up and is the threshold of clinical trials for patients with UC.</p>
</sec>
<sec id="section7-1359105311419268">
<title>The C-reactive protein (CRP)</title>
<p>Indicates inflammation: the normal value is inferior to 10mg/l. The higher and the faster the level of CRP increases, the more the inflammation is severe and the evolution of IBD is unfavorable. This data for the blood profile was provided by their physicians. It is part of standard monitoring of patients: no blood samples were taken for this study.</p>
</sec>
<sec id="section8-1359105311419268">
<title>The Clinical Global Impression (CGI)</title>
<p>(<xref ref-type="bibr" rid="bibr21-1359105311419268">Guy, 1976</xref>) has three independent items that are used in all studies in which the therapeutic setting or the effectiveness of a medical treatment is assessed. They are simple and adapted to all types of diseases. The first item (CGI1)<sup><xref ref-type="fn" rid="fn1-1359105311419268">1</xref></sup> assesses the gravity of the current disorder. In its initial use, this scale is used by physicians or caregivers but it can be used by patients in order to evaluate their medical condition on their own. Patients here self-rated this item in order to provide a simple indicator of their perception of their disease severity.</p>
</sec>
</sec>
<sec id="section9-1359105311419268">
<title>Psychological assessments</title>
<sec id="section10-1359105311419268">
<title>The Hospital Anxiety Depression (HAD)</title>
<p>scale is a self-screening for depression and anxiety in outpatients with 14 questions, seven for anxiety (HAD-A) and seven for depression (HAD-D) (<xref ref-type="bibr" rid="bibr51-1359105311419268">Zigmond &amp; Snaith, 1983</xref>). HAD was found to perform well in assessing cases of anxiety disorder and depression in somatic and psychiatric cases and their severity, and not only in hospital practice (<xref ref-type="bibr" rid="bibr25-1359105311419268">Herman, 1997</xref>). The cutoff value of 8 is often used (Hermann, 1997).</p>
</sec>
<sec id="section11-1359105311419268">
<title>13-item Beck Depression Inventory (BI)</title>
<p>is a questionnaire which quickly assesses a depressive state. It was developed by Beck in 1972 and assesses 13 symptoms: sadness, pessimism, sense of failure, dissatisfaction, culpability, self-dislike, suicidal ideation, social withdrawal, indecisiveness, negative modification of self-esteem, work difficulties, fatigability, and anorexia. The global score is obtained with the sum of the 13 items: a score between 0 and 4 represents no depression, between 5 and 8 milddepression, between 9 and 13 moderate depression, and a score superior to 14 represents severe depression (<xref ref-type="bibr" rid="bibr4-1359105311419268">Beck &amp; Beamesderfer, 1974</xref>).</p>
</sec>
<sec id="section12-1359105311419268">
<title>State-Trait Anxiety Inventory (STAI)</title>
<p>is an instrument for measuring anxiety in adults (<xref ref-type="bibr" rid="bibr46-1359105311419268">Spielberger, 1983</xref>). It differentiates between the temporary condition of ‘state anxiety’ and the more general and long-standing quality of ‘trait anxiety’. The STAI has forty questions with four possible responses for each one. The scores for the two scales are between 20 and 80. STAI has good reliability and validity and is useful to evaluate anxiety level and anxiety as a dimension of personality.</p>
</sec>
</sec>
<sec id="section13-1359105311419268">
<title>Sleep disturbances assessments</title>
<sec id="section14-1359105311419268">
<title>The Insomnia Severity Index (ISI)</title>
<p>Provides an index of the global severity of insomnia including perceived daytime consequences and distress (<xref ref-type="bibr" rid="bibr3-1359105311419268">Bastien, Vallières, Morin, 2001</xref>; <xref ref-type="bibr" rid="bibr40-1359105311419268">Morin &amp; Azrin, 1988</xref>). Scores from 0 to 7 represent ‘no clinically significant insomnia’, scores from 8 to 14 represent ‘sub-threshold insomnia’, scores from 15 to 21 represent ‘clinical insomnia’ (moderate severity), and scores from 22 to 28 represent ‘clinical insomnia’ (severe). ISI is a reliable and valid instrument to quantify perceived insomnia severity (<xref ref-type="bibr" rid="bibr3-1359105311419268">Bastien, Vallières, Morin, 2001</xref>).</p>
</sec>
<sec id="section15-1359105311419268">
<title>The Pittsburgh Sleep Quality Index (PSQI)</title>
<p>(<xref ref-type="bibr" rid="bibr10-1359105311419268">Buysse, Reynolds, Monk, Bernam, Kupfer, 1989</xref>) was developed to assess sleep quality during one month and to discriminate good and poor sleepers. The PSQI has 15 self-rated items on the frequency of sleep disturbances, subjective sleep quality, sleep latency, sleep duration, habitual sleeping effectiveness, use of sleeping medications and daytime dysfunction. Each component score ranges from 0 (no difficulty) to 3 (severe difficulty). The global score (from 0 to 21) is considered to be suggestive of significant sleeping disturbance. A score above 5 indicates sleep disturbances in two or more components. The PSQI has a high-test reliability and good validity for patients with primary insomnia (<xref ref-type="bibr" rid="bibr1-1359105311419268">Backhaus et al., 2002</xref>; <xref ref-type="bibr" rid="bibr31-1359105311419268">Knutson et al., 2006</xref>).</p>
</sec>
<sec id="section16-1359105311419268">
<title>The Epworth Sleepiness Scale (ESS)</title>
<p>Measures daytime sleepiness. The subject is asked to rate his probability of falling asleep on a scale of increasing probability from 0 to 3 in eight different situations. The scores for the eight questions are added to obtain a global score: a score ranging from 0 to 9 is considered to be normal, a score ranging from 10 to 24 is considered to indicate that the medical advice of a specialist should be recommended. The ESS has been well-validated in terms of its reproducibility in normal subjects and in sleep clinic patients (<xref ref-type="bibr" rid="bibr28-1359105311419268">Johns, 1991</xref>; <xref ref-type="bibr" rid="bibr31-1359105311419268">Knutson et al., 2006</xref>).</p>
</sec>
<sec id="section17-1359105311419268">
<title>Pain Assessment</title>
<p>Patients have to define their pain on a 10 point scale. Zero corresponds to no pain and 10 to maximum pain.</p>
</sec>
</sec>
</sec>
<sec id="section18-1359105311419268">
<title>Statistical procedure</title>
<p>In order to identify the profiles of patients who had the highest scores on the MFI global score, a CART procedure was applied. In the first step of the diagnostic tree construction, each of the explanatory variables is examined by considering all the possible modes of division. The best division is chosen according to a criterion which minimizes the residual variance and allows splitting the original sample into two subsets as homogeneous as possible. The division of the original group operates with a lower and a higher value than the value of division. This procedure is repeated for all the variables. The assignment of individuals to different groups (formed by successive segments) is thus based on the thresholds of the variables defined by the CART procedure which leads to the formation of groups as homogeneous as possible. Its interest in the understanding of IBD-related fatigue is: 1) to determine how the variables related to the disease itself and the psychological variables are organized in an optimal diagnosis (thus making it possible to identify what characterizes the most tired patients (on the right side of the tree) and 2) to show that the diagnoses are different for a general population or a specific population (men or women; in remission disease).</p>
</sec>
<sec id="section19-1359105311419268" sec-type="results">
<title>Results</title>
<p>When all patients were considered (see <xref ref-type="fig" rid="fig1-1359105311419268">Figure 1</xref>), the diagnostic variables are depressive mood (HAD-D &gt; 4.5), trait-anxiety (STAI YB &gt; 34.5) and daytime sleepiness (ESS &gt; 15.5).</p>
<p>Considering gender, for women (see <xref ref-type="fig" rid="fig2-1359105311419268">Figure 2</xref>), depressed mood is a fundamental criterion (HAD-D &gt; 2.5, BI &gt; 11.5).</p>
<fig id="fig1-1359105311419268" position="float">
<label>Figure 1.</label>
<caption>
<p>Diagnostic Tree of MFI global score for all patients with IBD</p>
</caption>
<graphic xlink:href="10.1177_1359105311419268-fig1.tif"/>
</fig>
<fig id="fig2-1359105311419268" position="float">
<label>Figure 2.</label>
<caption>
<p>Diagnostic tree of MFI global score for women with IBD</p>
</caption>
<graphic xlink:href="10.1177_1359105311419268-fig2.tif"/>
</fig>
<p>For men (see <xref ref-type="fig" rid="fig3-1359105311419268">Figure 3</xref>), this tree is the only one where CRP appears as a criterion of division. If, as for women, depression is the first criterion, one can notice that its threshold is higher (HAD-D &gt; 4.5). The following diagnostic variables are inflammation (CRP &gt; 5.5) and daytime sleepiness (ESS &gt; 8.5).</p>
<fig id="fig3-1359105311419268" position="float">
<label>Figure 3.</label>
<caption>
<p>Diagnostic tree of MFI global score for men with IBD</p>
</caption>
<graphic xlink:href="10.1177_1359105311419268-fig3.tif"/>
</fig>
<p>For disease in remission (see <xref ref-type="fig" rid="fig4-1359105311419268">Figure 4</xref>), depression is the first criterion (BI &gt; 6.5) followed by daytime sleepiness (ESS &gt; 12.5).</p>
<fig id="fig4-1359105311419268" position="float">
<label>Figure 4.</label>
<caption>
<p>Diagnostic tree of MFI global score for patients with inactive IBD</p>
</caption>
<graphic xlink:href="10.1177_1359105311419268-fig4.tif"/>
</fig>
</sec>
<sec id="section20-1359105311419268" sec-type="discussion">
<title>Discussion</title>
<p>The observation of the trees produced by the CART method confirmed that it can be a potentially useful aid in understanding how medical or psychological variables concerning IBD are organized in relation to each other. Moreover, depressed mood and sleep disturbances were found to be the most diagnostic variables while inflammation (assessed with CRP) was more secondary. This suggests that even if fatigue is primarily due to the disease, it is not solely explained by it. All these results are coherent with those found for IBD (Jelsness-Jørgensen et al., 2010) and for other chronic diseases in general (<xref ref-type="bibr" rid="bibr20-1359105311419268">Goldstein et al., 2006</xref>; <xref ref-type="bibr" rid="bibr23-1359105311419268">Harvey, Wadsworth, Wessley, Hotopf, 2008</xref>; <xref ref-type="bibr" rid="bibr5-1359105311419268">Bensing, Hulsman, Schreurs, 1999</xref>).</p>
<p>The CART procedure allows the practitioner to determine the most important variables to be taken into account, and to estimate the optimum decision thresholds. It defined cut-off points which were frequently lower than the predefined threshold levels for each of these tools. Even if among the most tired patients, patients were found who presented depressive mood, there were also patients among them who were not clinically depressive. If fatigue shares links with depression or sleep disturbances, it must not be confused with them.</p>
<p>This procedure makes it possible to identify patient profiles at risk by using classic clinical scales with specific scores in the context of the disease studied. In order to better treat these patients, it would be possible to systematically use these tools not only to identify patients with psychological suffering or presenting sleep disturbances (with their usual clinical scores), but also to more accurately identify patients at risk (with different threshold scores). Therefore, it would undoubtedly be pertinent to work beforehand with patients who have an inflammatory state, or low depression levels or with recognized sleep disturbances. Finally, this approach also helps to prevent depressive and anxious phases or to pinpoint the residual symptoms known to be factors of relapse (<xref ref-type="bibr" rid="bibr16-1359105311419268">Franzen &amp; Buysse, 2008</xref>; <xref ref-type="bibr" rid="bibr41-1359105311419268">Nutt, Wilson, Paterson, 2008</xref>; <xref ref-type="bibr" rid="bibr44-1359105311419268">Rienman &amp; Worshop Participants, 2009</xref>).</p>
<p>This study has some limitations, the most basic being its lack of matched patients (depressed vs. not depressed). Nevertheless, it underlines the contribution of the CART procedure to better understand fatigue. It also emphasizes the necessity of a longitudinal study (currently in progress) in order to determine the consistency and variation of the diagnostic factors involved over time and to consider other variables (anemia, physical or professional activity) that could influence fatigue. Finally, in identifying diagnostic variables, several therapeutic strategies (<xref ref-type="bibr" rid="bibr13-1359105311419268">Escalante &amp; Manzullo, 2009</xref>) as envisaged in other diseases (<xref ref-type="bibr" rid="bibr7-1359105311419268">Bol et al., 2010</xref>; <xref ref-type="bibr" rid="bibr30-1359105311419268">Kirshbaum, 2010</xref>; <xref ref-type="bibr" rid="bibr47-1359105311419268">Sprod, Hsieh, Hayward, Schneider, 2010</xref>) could improve the global fatigue of these patients.</p>
</sec>
</body>
<back>
<notes>
<fn-group>
<fn fn-type="other" id="fn1-1359105311419268">
<label>1.</label>
<p>1=normal, not at all ill; 2=borderline ill; 3=mildly ill; 4= moderately ill; 5=markedly ill; 6=severely ill; 7=extremely ill.</p>
</fn>
</fn-group>
</notes>
<ref-list>
<title>References</title>
<ref id="bibr1-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Backhaus</surname><given-names>J</given-names></name>
<name><surname>Junghanns</surname><given-names>K</given-names></name>
<name><surname>Broocks</surname><given-names>A</given-names></name>
<name><surname>Riemann</surname><given-names>D</given-names></name>
<name><surname>Hohagen</surname><given-names>F</given-names></name>
</person-group> (<year>2002</year>). <article-title>Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>53</volume>(<issue>3</issue>), <fpage>737</fpage>–<lpage>740</lpage>.</citation>
</ref>
<ref id="bibr2-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bardwell</surname><given-names>WA</given-names></name>
<name><surname>Ancoli-Israel</surname><given-names>S</given-names></name>
</person-group> (<year>2008</year>). <article-title>Breast cancer and fatigue</article-title>. <source>Sleep Medicine Clinics</source>, <volume>3</volume>(<issue>1</issue>), <fpage>61</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr3-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bastien</surname><given-names>C H</given-names></name>
<name><surname>Vallières</surname><given-names>A</given-names></name>
<name><surname>Morin</surname><given-names>C M</given-names></name>
</person-group> (<year>2001</year>). <article-title>Validation of the Insomnia Severity Index as an outcome measure of insomnia</article-title>. <source>Sleep Medicine</source>, <volume>2</volume>(<issue>4</issue>), <fpage>297</fpage>–<lpage>307</lpage>.</citation>
</ref>
<ref id="bibr4-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beck</surname><given-names>AT</given-names></name>
<name><surname>Beamesderfer</surname><given-names>A</given-names></name>
</person-group> (<year>1974</year>). <article-title>Assessment of depression: the depression inventory. Psychological measurements in psychopharmacology</article-title>. <source>Pharmacopsychiatry</source>, <volume>7</volume>, <fpage>151</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr5-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bensing</surname><given-names>JM</given-names></name>
<name><surname>Hulsman</surname><given-names>RL</given-names></name>
<name><surname>Schreurs</surname><given-names>K.M.</given-names></name>
</person-group> (<year>1999</year>). <article-title>Gender differences in fatigue: biopsychosocial factors relating to fatigue in men and women</article-title>. <source>Med Care</source>, <volume>37</volume>(<issue>10</issue>), <fpage>1078</fpage>–<lpage>1083</lpage>.</citation>
</ref>
<ref id="bibr6-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bodini</surname><given-names>B</given-names></name>
<name><surname>Mandarelli</surname><given-names>G</given-names></name>
<name><surname>Tomassini</surname><given-names>V</given-names></name>
<name><surname>Tarsitani</surname><given-names>L</given-names></name>
<name><surname>Pestalozza</surname><given-names>I</given-names></name>
<name><surname>Gasperini</surname><given-names>C</given-names></name>
<name><surname>Lenzi</surname><given-names>GL</given-names></name>
<name><surname>Pancheri</surname><given-names>P</given-names></name>
<name><surname>Pozzilli</surname><given-names>C</given-names></name>
</person-group> (<year>2008</year>). <article-title>Alexithymia in multiple sclerosis: relationship with fatigue and depression</article-title>. <source>Acta Neurologica Scandinavica</source>, <volume>118</volume>(<issue>1</issue>), <fpage>18</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr7-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bol</surname><given-names>Y</given-names></name>
<name><surname>Duits</surname><given-names>AA</given-names></name>
<name><surname>Lousberg</surname><given-names>R</given-names></name>
<name><surname>Hupperts</surname><given-names>RM</given-names></name>
<name><surname>Lacroix</surname><given-names>MH</given-names></name>
<name><surname>Verhey</surname><given-names>FR</given-names></name>
<name><surname>Vlaeyen</surname><given-names>JW</given-names></name>
</person-group> (<year>2010</year>). <article-title>Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling</article-title>. <source>Journal of Behavioral Medicine</source>, <volume>33</volume>(<issue>5</issue>), <fpage>355</fpage>–<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr8-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borneman</surname><given-names>T</given-names></name>
<name><surname>Piper</surname><given-names>B F</given-names></name>
<name><surname>Chi-Yi Sun</surname><given-names>V</given-names></name>
<name><surname>Koczywas</surname><given-names>M</given-names></name>
<name><surname>Uman</surname><given-names>G</given-names></name>
<name><surname>Ferrell</surname><given-names>B</given-names></name>
</person-group> (<year>2007</year>). <article-title>Implementing the Fatigue Guidelines at One NCCN Member Institution: Process and Outcomes</article-title>. <source>Journal of the National Comprehensive Cancer Network</source>, <volume>5</volume>(<issue>10</issue>), <fpage>1092</fpage>–<lpage>1101</lpage>.</citation>
</ref>
<ref id="bibr9-1359105311419268">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Breiman</surname><given-names>L</given-names></name>
<name><surname>Friedman</surname><given-names>JH</given-names></name>
<name><surname>Olshen</surname><given-names>RA</given-names></name>
<name><surname>Stone</surname><given-names>CJ</given-names></name>
</person-group> (<year>1987</year>). <source>Classification and Regression Tree</source>. <publisher-loc>NewYork</publisher-loc>: <publisher-name>Wadsworth publishing Company</publisher-name>.</citation>
</ref>
<ref id="bibr10-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buysse</surname><given-names>D J</given-names></name>
<name><surname>Reynolds</surname><given-names>C F</given-names></name>
<name><surname>Monk</surname><given-names>T H</given-names></name>
<name><surname>Bernam</surname><given-names>S F</given-names></name>
<name><surname>Kupfer</surname><given-names>D J</given-names></name>
</person-group> (<year>1989</year>). <article-title>The Pittsburgh Quality Sleep Index: a new instrument for psychiatric practice and research</article-title>. <source>Psychiatry Research</source>, <volume>28</volume>(<issue>2</issue>), <fpage>193</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr11-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Colombet</surname><given-names>I</given-names></name>
<name><surname>Ruelland</surname><given-names>A</given-names></name>
<name><surname>Chatellier</surname><given-names>G</given-names></name>
<name><surname>Gueyffier</surname><given-names>F</given-names></name>
<name><surname>Degoulet</surname><given-names>P</given-names></name>
<name><surname>Jaulent</surname><given-names>MC</given-names></name>
</person-group> (<year>2000</year>). <article-title>Models to predict cardiovascular risk: comparaison of CART, Multilayer Perceptron and Logistic Regression</article-title>. <source>Proc AMIA Symp</source>, <fpage>156</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr12-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Iudicibus</surname><given-names>S</given-names></name>
<name><surname>Stocco</surname><given-names>G</given-names></name>
<name><surname>Martelossi</surname><given-names>S</given-names></name>
<name><surname>Londero</surname><given-names>M</given-names></name>
<name><surname>Ebner</surname><given-names>E</given-names></name>
<name><surname>Pontillo</surname><given-names>A</given-names></name>
<name><surname>Lionetti</surname><given-names>P</given-names></name>
<name><surname>Barabino</surname><given-names>A</given-names></name>
<name><surname>Bartoli</surname><given-names>F</given-names></name>
<name><surname>Ventura</surname><given-names>A</given-names></name>
<name><surname>Decorti</surname><given-names>G</given-names></name>
</person-group> (<year>2011</year>). <article-title>Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases</article-title>. <source>Journal of Clinical Gastroenterology</source>, <volume>45</volume> (<issue>1</issue>),<fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr13-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Escalante</surname><given-names>CP</given-names></name>
<name><surname>Manzullo</surname><given-names>EF</given-names></name>
</person-group> (<year>2009</year>). <article-title>Cancer-related fatigue: the approach and treatment</article-title>. <source>Journal of General Internal Medicine</source>, <volume>24</volume>, <fpage>S412</fpage>–<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr14-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fava</surname><given-names>M</given-names></name>
</person-group> (<year>2004</year>). <article-title>Daytime sleepiness and insomnia correlates of depression</article-title>. <source>Journal of Clinical Psychiatry</source>, <volume>65</volume>(<issue>16</issue>), <fpage>27</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr15-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Flett</surname><given-names>GL</given-names></name>
<name><surname>Baricza</surname><given-names>C</given-names></name>
<name><surname>Gupta</surname><given-names>A</given-names></name>
<name><surname>Hewitt</surname><given-names>PL</given-names></name>
<name><surname>Endler</surname><given-names>NS</given-names></name>
</person-group> (<year>2011</year>). <article-title>Perfectionism, psychosocial impact and coping with irritable bowel disease: a study of patients with Crohn’s disease and ulcerative colitis</article-title>. <source>Journal of Health Psychology</source>, <volume>16</volume>, <fpage>561</fpage>–<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr16-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franzen</surname><given-names>PL</given-names></name>
<name><surname>Buysse</surname><given-names>DJ</given-names></name>
</person-group> (<year>2008</year>). <article-title>Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications</article-title>. <source>Dialogues in Clinical Neurosciences</source>, <volume>10</volume>(<issue>4</issue>), <fpage>473</fpage>–<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr17-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fuhrer</surname><given-names>R</given-names></name>
<name><surname>Wessely</surname><given-names>S</given-names></name>
</person-group> (<year>1995</year>). <article-title>The epidemiology of fatigue and depression: a French primary-care study</article-title>. <source>Psychol Med.</source>, <volume>25</volume>(<issue>5</issue>), <fpage>895</fpage>–<lpage>905</lpage>.</citation>
</ref>
<ref id="bibr18-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garzotto</surname><given-names>M</given-names></name>
<name><surname>Beer</surname><given-names>TM</given-names></name>
<name><surname>Hudson</surname><given-names>RG</given-names></name>
<name><surname>Peters</surname><given-names>L</given-names></name>
<name><surname>Hsieh</surname><given-names>YC</given-names></name>
<name><surname>Barrera</surname><given-names>E</given-names></name>
<name><surname>Klein</surname><given-names>T</given-names></name>
<name><surname>Mori</surname><given-names>M</given-names></name>
</person-group> (<year>2005</year>). <article-title>Improved detection of prostate cancer using classification and regression tree analysis</article-title>. <source>Journal of Clinical Oncology</source>, <volume>23</volume>(<issue>19</issue>), <fpage>4322</fpage>–<lpage>4329</lpage>.</citation>
</ref>
<ref id="bibr19-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gentile</surname><given-names>S</given-names></name>
<name><surname>Delarozière</surname><given-names>JC</given-names></name>
<name><surname>Favre</surname><given-names>F</given-names></name>
<name><surname>Sambuc</surname><given-names>R</given-names></name>
<name><surname>San Marco</surname><given-names>JL</given-names></name>
</person-group> (<year>2003</year>). <article-title>Validation of the French ‘multidimensional fatigue inventory’ (MFI 20)</article-title>. <source>European Journal of Cancer Care</source>, <volume>12</volume>(<issue>1</issue>), <fpage>58</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr20-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goldstein</surname><given-names>D</given-names></name>
<name><surname>Bennett</surname><given-names>B</given-names></name>
<name><surname>Friedlander</surname><given-names>M</given-names></name>
<name><surname>Davenport</surname><given-names>T</given-names></name>
<name><surname>Hickie</surname><given-names>I</given-names></name>
<name><surname>Lloyd</surname><given-names>A</given-names></name>
</person-group> (<year>2006</year>). <article-title>Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study</article-title>. <source>BMC Cancer</source>, <volume>9</volume>(<issue>6</issue>), <fpage>240</fpage>.</citation>
</ref>
<ref id="bibr21-1359105311419268">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Guy</surname><given-names>W</given-names></name>
</person-group> (<year>1976</year>). <source>Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>National Institute of Mental Health</publisher-name>.</citation>
</ref>
<ref id="bibr22-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hall</surname><given-names>NJ</given-names></name>
<name><surname>Rubin</surname><given-names>GP</given-names></name>
<name><surname>Dougall</surname><given-names>A</given-names></name>
<name><surname>Hungin</surname><given-names>APS</given-names></name>
<name><surname>Neely</surname><given-names>J</given-names></name>
</person-group> (<year>2005</year>). <article-title>The fight for ‘health-related normality’: a qualitative study of the experiences of individuals living with established Inflammatory Bowel Disease (IBD)</article-title>. <source>Journal of Health Psychology</source>, <volume>10</volume>(<issue>3</issue>), <fpage>443</fpage>–<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr23-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>SB</given-names></name>
<name><surname>Wadsworth</surname><given-names>M</given-names></name>
<name><surname>Wessley</surname><given-names>S</given-names></name>
<name><surname>Hotopf</surname><given-names>M</given-names></name>
</person-group> (<year>2008</year>). <article-title>The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study</article-title>. <source>Psychological Medicine</source>, <volume>38</volume>(<issue>7</issue>), <fpage>933</fpage>–<lpage>940</lpage>.</citation>
</ref>
<ref id="bibr24-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Häuser</surname><given-names>W</given-names></name>
<name><surname>Janke</surname><given-names>KH</given-names></name>
<name><surname>Klump</surname><given-names>B</given-names></name>
<name><surname>Hinz</surname><given-names>A</given-names></name>
</person-group> (<year>2011</year>). <article-title>Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population</article-title>. <source>Inflammatory Bowel Disorder</source>, <volume>17</volume>(<issue>2</issue>), <fpage>621</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr25-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herman</surname><given-names>C</given-names></name>
</person-group> (<year>1997</year>). <article-title>International experience with the Hospital Anxiety and Depression scale. A review of validation date and clinical results</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>42</volume>(<issue>1</issue>), <fpage>17</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr26-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hess</surname><given-names>KR</given-names></name>
<name><surname>Abbruzzese</surname><given-names>MC</given-names></name>
<name><surname>Lenzi</surname><given-names>R</given-names></name>
<name><surname>Raber</surname><given-names>MN</given-names></name>
<name><surname>Abbruzzese</surname><given-names>JL</given-names></name>
</person-group> (<year>1999</year>). <article-title>Classification and Regression Tree analysis of 1000 consecutive patients with unknown primary carcinoma</article-title>. <source>Clinical Cancer Research</source>, <volume>5</volume>(<issue>11</issue>), <fpage>3403</fpage>–<lpage>3410</lpage>.</citation>
</ref>
<ref id="bibr27-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jelsness-Jørgensen</surname><given-names>LP</given-names></name>
<name><surname>Bernklev</surname><given-names>T</given-names></name>
<name><surname>Henriksen</surname><given-names>M</given-names></name>
<name><surname>Torp</surname><given-names>R</given-names></name>
<name><surname>Moum</surname><given-names>BA</given-names></name>
</person-group> (<year>2011</year>). <article-title>Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls</article-title>. <source>Inflammatory Bowel Disorder</source>, <volume>17</volume>(<issue>7</issue>), <fpage>1564</fpage>–<lpage>1572</lpage>.</citation>
</ref>
<ref id="bibr28-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johns</surname><given-names>MW</given-names></name>
</person-group> (<year>1991</year>). <article-title>A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale</article-title>. <source>Sleep</source>, <volume>14</volume>(<issue>6</issue>), <fpage>50</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr29-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaplan</surname><given-names>KA</given-names></name>
<name><surname>Harvey</surname><given-names>AG</given-names></name>
</person-group> (<year>2009</year>). <article-title>Hypersomnia across mood disorders: a review and synthesis</article-title>. <source>Sleep Medicine Reviews</source>, <volume>13</volume>(<issue>4</issue>), <fpage>275</fpage>–<lpage>285</lpage>.</citation>
</ref>
<ref id="bibr30-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirshbaum</surname><given-names>M</given-names></name>
</person-group> (<year>2010</year>). <article-title>Cancer-related fatigue: a review of nursing interventions</article-title>. <source>British Journal of Community Nursing</source>, <volume>15</volume>(<issue>5</issue>), <fpage>214</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr31-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knutson</surname><given-names>KL</given-names></name>
<name><surname>Rathouz</surname><given-names>PJ</given-names></name>
<name><surname>Yan</surname><given-names>LL</given-names></name>
<name><surname>Liu</surname><given-names>K</given-names></name>
<name><surname>Lauderdale</surname><given-names>DS</given-names></name>
</person-group> (<year>2006</year>). <article-title>Stability of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness questionnaires over 1 year in early middle-aged adults: the CARDIA study</article-title>. <source>Sleep</source>, <volume>29</volume>(<issue>11</issue>), <fpage>1503</fpage>–<lpage>1506</lpage>.</citation>
</ref>
<ref id="bibr32-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kovács</surname><given-names>Z</given-names></name>
<name><surname>Kovács</surname><given-names>F</given-names></name>
</person-group> (<year>2007</year>). <article-title>Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease</article-title>. <source>International Journal of Psychiatry in Medicine</source>, <volume>37</volume>(<issue>3</issue>), <fpage>245</fpage>–<lpage>255</lpage>.</citation>
</ref>
<ref id="bibr33-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lichtiger</surname><given-names>S</given-names></name>
<name><surname>Present</surname><given-names>DH</given-names></name>
<name><surname>Kornbluth</surname><given-names>A</given-names></name>
<name><surname>Gelernt</surname><given-names>I</given-names></name>
<name><surname>Bauer</surname><given-names>J</given-names></name>
<name><surname>Galler</surname><given-names>G</given-names></name>
<name><surname>Michelassi</surname><given-names>F</given-names></name>
<name><surname>Hanauer</surname><given-names>S</given-names></name>
</person-group> (<year>1994</year>). <article-title>Cyclosporine in severe ulcerative colitis refractory to steroid therapy</article-title>. <source>New England Journal of Medicine</source>, <volume>330</volume>(<issue>26</issue>), <fpage>1841</fpage>–<lpage>1845</lpage>.</citation>
</ref>
<ref id="bibr34-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lemon</surname><given-names>SC</given-names></name>
<name><surname>Roy</surname><given-names>J</given-names></name>
<name><surname>Clark</surname><given-names>MA</given-names></name>
<name><surname>Friedmann</surname><given-names>PD</given-names></name>
<name><surname>Rakowski</surname><given-names>W</given-names></name>
</person-group> (<year>2003</year>). <article-title>Classification and regression tree analysis in public health: methodological review and comparison with logistic regression</article-title>. <source>Annals of Behavioral Medicine</source>, <volume>26</volume>(<issue>3</issue>), <fpage>172</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr35-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mañosa</surname><given-names>M</given-names></name>
<name><surname>Cabré</surname><given-names>E</given-names></name>
<name><surname>Garcia-Planella</surname><given-names>E</given-names></name>
<name><surname>Bernal</surname><given-names>I</given-names></name>
<name><surname>Gordillo</surname><given-names>J</given-names></name>
<name><surname>Esteve</surname><given-names>M</given-names></name>
<name><surname>Zabana</surname><given-names>Y</given-names></name>
<name><surname>Gassull</surname><given-names>MA</given-names></name>
<name><surname>Domènech</surname><given-names>E</given-names></name>
</person-group> (<year>2011</year>). <article-title>Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids</article-title>. <source>Inflammatory Bowel Disorder</source>.</citation>
</ref>
<ref id="bibr36-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manzullo</surname><given-names>EF</given-names></name>
<name><surname>Escalante</surname><given-names>CP</given-names></name>
</person-group> (<year>2002</year>). <article-title>Research into fatigue</article-title>. <source>Hematology Oncoly Clinics of North America</source>, <volume>16</volume>(<issue>3</issue>), <fpage>619</fpage>–<lpage>628</lpage>.</citation>
</ref>
<ref id="bibr37-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matsuda</surname><given-names>Y</given-names></name>
<name><surname>Mastui</surname><given-names>T</given-names></name>
<name><surname>Kataoka</surname><given-names>K</given-names></name>
<name><surname>Fukada</surname><given-names>S</given-names></name>
<name><surname>Kuratsune</surname><given-names>H</given-names></name>
<name><surname>Tajima</surname><given-names>S</given-names></name>
<name><surname>Yamaguti</surname><given-names>K</given-names></name>
<name><surname>Kato</surname><given-names>YH</given-names></name>
<name><surname>Kiriike</surname><given-names>N</given-names></name>
</person-group> (<year>2009</year>). <article-title>A two-years follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders</article-title>. <source>Psychiatry and Clinical Neurosciences</source>, <volume>63</volume>(<issue>3</issue>), <fpage>364</fpage>–<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr38-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mikocka-Walus</surname><given-names>AA</given-names></name>
<name><surname>Turnbull</surname><given-names>DA</given-names></name>
<name><surname>Andrews</surname><given-names>JM</given-names></name>
<name><surname>Moulding</surname><given-names>NT</given-names></name>
<name><surname>Holtmann</surname><given-names>GJ</given-names></name>
</person-group> (<year>2008</year>). <article-title>The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease</article-title>. <source>Alimentary Pharmacology and Therapeutics</source>, <volume>28</volume>(<issue>4</issue>), <fpage>475</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr39-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Minderhoud</surname><given-names>IM</given-names></name>
<name><surname>Oldenburg</surname><given-names>B</given-names></name>
<name><surname>van Dam</surname><given-names>PS</given-names></name>
<name><surname>van Berge Henegouwen</surname><given-names>GP</given-names></name>
</person-group> (<year>2003</year>). <article-title>High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency</article-title>. <source>American Journal of Gastroenterology</source>, <volume>98</volume>(<issue>5</issue>), <fpage>1088</fpage>–<lpage>1093</lpage>.</citation>
</ref>
<ref id="bibr40-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morin</surname><given-names>C M</given-names></name>
<name><surname>Azrin</surname><given-names>N H</given-names></name>
</person-group> (<year>1988</year>). <article-title>Behavioral and cognitive treatments of geriatric insomnia</article-title>. <source>Journal of Consulting and Clinical Psychology</source>, <volume>56</volume>(<issue>5</issue>), <fpage>748</fpage>–<lpage>753</lpage>.</citation>
</ref>
<ref id="bibr41-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nutt</surname><given-names>D</given-names></name>
<name><surname>Wilson</surname><given-names>S</given-names></name>
<name><surname>Paterson</surname><given-names>L</given-names></name>
</person-group> (<year>2008</year>). <article-title>Sleep disorders as core symptoms of depression</article-title>. <source>Dialogues Clinical Neurosciences</source>, <volume>10</volume>(<issue>3</issue>), <fpage>329</fpage>–<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr42-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raison</surname><given-names>CL</given-names></name>
<name><surname>Lin</surname><given-names>JM</given-names></name>
<name><surname>Reeves</surname><given-names>WC</given-names></name>
</person-group> (<year>2009</year>). <article-title>Association of peripheral inflammatory markers with chronic fatigue in a population-based sample</article-title>. <source>Brain, Behavior and Immunity</source>, <volume>23</volume>(<issue>3</issue>), <fpage>327</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr43-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ranjbaran</surname><given-names>Z</given-names></name>
<name><surname>Keefer</surname><given-names>L</given-names></name>
<name><surname>Stepanski</surname><given-names>E</given-names></name>
<name><surname>Farhadi</surname><given-names>A</given-names></name>
<name><surname>Keshvarian</surname><given-names>A</given-names></name>
</person-group> (<year>2007</year>). <article-title>The relevance of sleep abnormalities to chronic inflammatory conditions</article-title>. <source>Inflammation Research</source>, <volume>56</volume>(<issue>2</issue>), <fpage>51</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr44-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rienmann</surname><given-names>D</given-names></name>
</person-group>(<collab>Workshop Participants</collab>) (<year>2009</year>). <article-title>Does effective management of sleep disorders reduce depressive symptoms and risk of depression</article-title>. <source>Drugs</source>, <volume>69</volume>(<issue>2</issue>), <fpage>43</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr45-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smets</surname><given-names>E M</given-names></name>
<name><surname>Garssen</surname><given-names>B</given-names></name>
<name><surname>Bonke</surname><given-names>B</given-names></name>
<name><surname>De Haes</surname><given-names>J C J M</given-names></name>
</person-group> (<year>1995</year>). <article-title>The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>39</volume>(<issue>5</issue>), <fpage>315</fpage>–<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr46-1359105311419268">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Spielberger</surname><given-names>CD</given-names></name>
<name><surname>Gorsuch</surname><given-names>RC</given-names></name>
<name><surname>Lushene</surname><given-names>RE</given-names></name>
<name><surname>Vagg</surname><given-names>PR</given-names></name>
<name><surname>Jacobs</surname><given-names>GA</given-names></name>
</person-group> (<year>1983</year>). <source>Manual for the State-Trait Anxiety Inventory</source>. <publisher-loc>Palo Alto</publisher-loc>: <publisher-name>Consulting Psychologists Press</publisher-name>.</citation>
</ref>
<ref id="bibr47-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sprod</surname><given-names>LK</given-names></name>
<name><surname>Hsieh</surname><given-names>CC</given-names></name>
<name><surname>Hayward</surname><given-names>R</given-names></name>
<name><surname>Schneider</surname><given-names>CM</given-names></name>
</person-group> (<year>2010</year>). <article-title>Three versus six months of exercise training in breast cancer survivors</article-title>. <source>Breast Cancer Research and Treatment</source>, <volume>121</volume>(<issue>2</issue>), <fpage>413</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr48-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teixeira</surname><given-names>A</given-names></name>
</person-group> (<year>2004</year>). <article-title>Analyse discriminante par arbre de décision binaire</article-title>. <source>Revue des Maladies Respiratoires</source>, <volume>21</volume>, <fpage>1174</fpage>–<lpage>1176</lpage>.</citation>
</ref>
<ref id="bibr49-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van Langenberg</surname><given-names>DR</given-names></name>
<name><surname>Gibson</surname><given-names>PR</given-names></name>
</person-group> (<year>2010</year>). <article-title>Systematic review: fatigue in inflammatory bowel disease</article-title>. <source>Aliment Pharmacology &amp; Therapeutics</source>, <volume>32</volume>(<issue>2</issue>), <fpage>131</fpage>–<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr50-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>N</given-names></name>
<name><surname>Stewart</surname><given-names>R</given-names></name>
<name><surname>Jenkins</surname><given-names>R</given-names></name>
<name><surname>Bhugra</surname><given-names>DK</given-names></name>
<name><surname>Furukawa</surname><given-names>TA</given-names></name>
</person-group> (<year>2008</year>). <article-title>The epidemiology of chronic fatigue, physical illness, and symptoms of common mental disorders: a cross-sectional survey from the second British National Survey of Psychiatric Morbidity</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>64</volume>(<issue>4</issue>), <fpage>357</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr51-1359105311419268">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zigmond</surname><given-names>A S</given-names></name>
<name><surname>Snaith</surname><given-names>R P</given-names></name>
</person-group> (<year>1983</year>). <article-title>The Hospital Anxiety and Depression Scale</article-title>. <source>Acta Psychiatrica Scandinavica</source>, <volume>67</volume>, <fpage>361</fpage>–<lpage>370</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>